Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(206)
•••
scarlet1967
X
View Profile
View Bullboard History
Comment by
scarlet1967
on Dec 23, 2024 2:58pm
RE:RE:HIV lipodystrophy causes morbidity and mortality
"Conflict of interest statement Potential conflicts of interest. A. M. B., H. R., and S. M. S. are employees of Broadstreet HEOR, which
...more
(48)
•••
Mannequin
X
View Profile
View Bullboard History
Comment by
Mannequin
on Dec 23, 2024 2:10pm
RE:RE:RE:RE:HIV lipodystrophy causes morbidity and mortality
Here is a dumbed down video. Its actually very good. https://www.youtube.com/watch?v=6iu07e1_us8
(973)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Dec 23, 2024 2:03pm
RE:Scorecard: Five positive announcements expected by May 2025
Thanks Joe, Simple and succinct. But if F8 =reboot .... make it easy.
(973)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Dec 23, 2024 1:56pm
RE:RE:RE:HIV lipodystrophy causes morbidity and mortality
I'm not asking for me. Sorry my point wasn't more clear. All science projects run the risk of fading into obscurity without funding. Without money from dummies like me, not just me, this
...more
(64)
•••
PWIB123
X
View Profile
View Bullboard History
Comment by
PWIB123
on Dec 22, 2024 10:27pm
RE:RE:HIV lipodystrophy causes morbidity and mortality
Careful Maxmoe. Scarlett is highly regarded as one of the best researchers on this board for those of us who know less about the science. You've already lost any credibility you
...more
(973)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Dec 22, 2024 9:45pm
RE:HIV lipodystrophy causes morbidity and mortality
WC may be a useful and cost-effective surrogate for visceral adiposity, which is an important marker of morbidity and mortality among PWH." Translation ???? Investors have no idea what the
...more
(214)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Dec 21, 2024 10:04am
RE:HIV lipodystrophy causes morbidity and mortality
Levesque was described as a marketing guru when Dawn hired him Yet the number of patients on Egrifta is still under one thousand ( as far as I know) whereas the addressable market is over 15000
...more
(32)
•••
muslix1
X
View Profile
View Bullboard History
Comment by
muslix1
on Dec 21, 2024 8:30am
RE:Scorecard: Five positive announcements expected by May 2025
i hope Santa will read your Chirstmas list Joemare....Lol
(206)
•••
scarlet1967
X
View Profile
View Bullboard History
Post by
scarlet1967
on Dec 20, 2024 7:44pm
HIV lipodystrophy causes morbidity and mortality
Maybe the drug shortage staff should accelerate their efforts in order for FDA to expedite their PAS review. HIV lipodystrophy often takes far too long to get diagnosed and all those patients who
...more
(43)
•••
Lee430
X
View Profile
View Bullboard History
Comment by
Lee430
on Dec 20, 2024 4:00pm
RE:Excellent
Why would Thera not PR something on the Tryngolza FDA approval yesterday?
(38)
•••
Joemare
X
View Profile
View Bullboard History
Post by
Joemare
on Dec 20, 2024 3:50pm
Scorecard: Five positive announcements expected by May 2025
1) Egrifta inventory resolved - mid January 2025 2) Partner with sortilin plateform - jan/feb 2025 3)F8 Egrifta - march/april 2025 4)Filing Ionis drug - May 2025 5)Positive financials - sales and
...more
(115)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Dec 20, 2024 2:04pm
RE:RE:RE:Excellent
Sure why not... it went to 12$ (48%$ today) twice in the past 30 years on the back of... nothing really... no sales, no fundamentals.. just went up thanks to good PR and some BS back then...
(2)
•••
CreatingApe
X
View Profile
View Bullboard History
Comment by
CreatingApe
on Dec 20, 2024 1:05pm
RE:RE:Excellent
That or we can continue this steady healthy climb back up :)
(115)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Dec 20, 2024 8:40am
RE:Excellent
Sellers are lining up this morning now that most of the good news seems to be out. We will now probably settle for the next thing called the sorthage or lack of before mid january. Also
...more
(214)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Dec 19, 2024 6:20pm
RE:RE:IONS drug was approved today as expected
https://seekingalpha.com/news/4388789-ionis-gets-fda-approval-for-tryngolza
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.